Search results for "Pseudomonas infection"

showing 10 items of 29 documents

The rise and the fall of a Pseudomonas aeruginosa endemic lineage in a hospital

2021

The biological features that allow a pathogen to survive in the hospital environment are mostly unknown. The extinction of bacterial epidemics in hospitals is mostly attributed to changes in medical practice, including infection control, but the role of bacterial adaptation has never been documented. We analysed a collection of Pseudomonas aeruginosa isolates belonging to the Besançon Epidemic Strain (BES), responsible for a 12year nosocomial outbreak, using a genotype-to-phenotype approach. Bayesian analysis estimated the emergence of the clone in the hospital 5 years before its opening, during the creation of its water distribution network made of copper. BES survived better than the refe…

DNA Bacterialparallel evolutionLineage (genetic)Genomic IslandsPathogens and EpidemiologyBiologymedicine.disease_causeAmoeba (operating system)Disease OutbreaksMicrobiology03 medical and health sciencesAntibiotic resistanceDrug Resistance Multiple BacterialGenomic islandbacterial pathogensmedicineHumansPseudomonas InfectionsPathogenGenome size[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyResearch Articles030304 developmental biology0303 health sciencesoutbreak030306 microbiologyPseudomonas aeruginosahigh-risk cloneOutbreakBayes TheoremSequence Analysis DNAGeneral MedicineHospitals3. Good healthPhenotype[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyPseudomonas aeruginosa
researchProduct

Novel Paraoxonase 2-Dependent Mechanism Mediating the Biological Effects of the Pseudomonas aeruginosa Quorum-Sensing Molecule N-(3-Oxo-Dodecanoyl)-l…

2015

ABSTRACT Pseudomonas aeruginosa produces N -(3-oxo-dodecanoyl)- l -homoserine lactone (3OC12), a crucial signaling molecule that elicits diverse biological responses in host cells thought to subvert immune defenses. The mechanism mediating many of these responses remains unknown. The intracellular lactonase paraoxonase 2 (PON2) hydrolyzes and inactivates 3OC12 and is therefore considered a component of host cells that attenuates 3OC12-mediated responses. Here, we demonstrate in cell lines and in primary human bronchial epithelial cells that 3OC12 is rapidly hydrolyzed intracellularly by PON2 to 3OC12 acid, which becomes trapped and accumulates within the cells. Subcellularly, 3OC12 acid acc…

ImmunologyBlotting WesternHomoserineMitochondrionMicrobiologyCell LineHost-Parasite Interactionschemistry.chemical_compoundLactonesLactonaseHomoserineHumansImmunoprecipitationPseudomonas InfectionsChromatography High Pressure LiquidCellular Microbiology: Pathogen-Host Cell Molecular InteractionsMicroscopy ConfocalbiologyKinaseAryldialkylphosphataseQuorum SensingQuorum sensingCytosolInfectious DiseasesBiochemistrychemistryPseudomonas aeruginosabiology.proteinPhosphorylationParasitologyRNA InterferenceIntracellular
researchProduct

1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A

2020

The inhibition or prevention of biofilm formation represents an emerging strategy in the war against antibiotic resistance, interfering with key players in bacterial virulence. This approach includes the inhibition of the catalytic activity of transpeptidase sortase A (Srt A), a membrane enzyme responsible for covalently attaching a wide variety of adhesive matrix molecules to the peptidoglycan cell wall in Gram-positive strains. A new series of seventeen 1,2,4-oxadiazole derivatives was efficiently synthesized and screened as potential new anti-virulence agents. The ability of inhibiting biofilm formation was evaluated against both Gram-positive and Gram-negative pathogens. Remarkably, all…

Indoles124-Oxadiazoles Antibiofilm activity Sortase A inhibitors Anti-virulence agents Marine alkaloids Topsentin analogs01 natural scienceslaw.inventionchemistry.chemical_compoundMarine alkaloidslawDrug DiscoveryPathogenchemistry.chemical_classificationOxadiazoles0303 health sciencesChemistry4-OxadiazolesImidazolesGeneral MedicineStaphylococcal InfectionsAminoacyltransferasesAnti-Bacterial AgentsCysteine EndopeptidasesAnti-virulence agentsBiochemistrySortase AAntibiofilm activityPseudomonas aeruginosaTopsentin analogsRecombinant DNA124-Oxadiazoles; Anti-virulence agents; Antibiofilm activity; Marine alkaloids; Sortase A inhibitors; Topsentin analogsStaphylococcus aureus12Sortase A inhibitorsCell LineCell wall03 medical and health sciencesAntibiotic resistanceBacterial Proteins124-OxadiazolesHumansPseudomonas Infections030304 developmental biologyPharmacology010405 organic chemistryOrganic ChemistryBiofilmSettore CHIM/08 - Chimica Farmaceutica0104 chemical sciencesEnzymeBiofilmsPeptidoglycan
researchProduct

Quality standards for the management of bronchiectasis in Italy: A national audit

2016

Although historically considered a neglected disease, bronchiectasis has become a disease of renewed interest over recent decades in light of an increase in prevalence and a substantial burden on healthcare systems. In 2010, the British Thoracic Society (BTS) published guidelines on the management of bronchiectasis in adults, along with specific quality standards. To date, these represent the only quality standards available in Europe. These have been tested over a number of years in the UK with progressive improvements in the standard of care. No national guidelines are available in Italy and no indications on which guideline should be followed have been given by the Italian Society of Res…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtybronchiectasismedia_common.quotation_subjectSymptom Flare UpMedical auditSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciences0302 clinical medicinemedicinePrevalenceHumansQuality (business)Pseudomonas Infections030212 general & internal medicineIntensive care medicineNational auditmedia_commonAgedMedical AuditBronchiectasisbusiness.industryMedicine (all)Middle Agedmedicine.diseaseSymptom Flare UpAnti-Bacterial AgentsPatient Care Management030228 respiratory systemItalyNeeds assessmentPseudomonas aeruginosaFemalebusinessMedicine (all); Pulmonary and Respiratory MedicineNeeds Assessment
researchProduct

Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTSc…

2014

International audience; The identification of temporal clusters of healthcare-associated colonizations or infections is a challenge in infection control. WHONET software is available to achieve these objectives using laboratory databases of hospitals but it has never been compared with SaTScan regarding its detection performance. This study provided the opportunity to evaluate the performance of WHONET software in comparison with SaTScan software as a reference to detect clusters of Pseudomonas aeruginosa. A retrospective study was conducted in two French university hospitals. Cases of P. aeruginosa colonizations or infections occurring between 1st January 2005 and 30th April 2014 in the fi…

Male[SDE] Environmental Scienceslcsh:MedicineInfection controlmedicine.disease_causeDisease OutbreaksHospitals University0302 clinical medicineSoftware[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyCluster AnalysisInfection controlSoftware toolsPoisson Distribution030212 general & internal medicinelcsh:ScienceCross InfectionMultidisciplinaryIncidenceIncidence (epidemiology)University hospital3. Good healthMonte Carlo method[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyWater pollutionPseudomonas aeruginosa[SDE]Environmental SciencesFemaleResearch ArticleHealthcare associated infectionsmedicine.medical_specialtyPermutation030231 tropical medicineMicrobiology03 medical and health sciencesNosocomial infectionsmedicineHumansPseudomonas InfectionsIntensive care medicineUnit levelAgedRetrospective StudiesPseudomonas aeruginosabusiness.industrylcsh:RBacteriologyRetrospective cohort study[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieEmergency medicinelcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessSoftware
researchProduct

Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care…

2008

Aim: We describe a one-year investigation of colonization by imipenemresistant, metallo-β-lactamase (MBL) producing Pseudomonas aeruginosa in a neonatal intensive care unit (NICU) of the University Hospital of Palermo, Italy. Methods: A prospective epidemiological investigation was conducted in the period 2003 January to 2004 January. Rectal swabs were collected twice a week from all neonates throughout their NICU stay. MBL production by imipenem-resistant strains of P aeruginosa was detected by phenotypic and molecular methods. Pulsed field gel electrophoresis (PFGE) was carried out on all isolates of P aeruginosa. The association between risk factors and colonization by imipenem-resistant…

Malemedicine.medical_specialtyImipenemNeonatal intensive care unitSettore MED/17 - Malattie Infettivemetallo-β-lactamaseDrug resistanceMicrobial Sensitivity TestsBreast milkmedicine.disease_causeMicrobiologyRisk FactorsDrug Resistance Multiple BacterialIntensive Care Units NeonatalEpidemiologymedicinePulsed-field gel electrophoresisHumansPharmacology (medical)ColonizationPseudomonas InfectionsProspective StudiesProportional Hazards ModelsPharmacologyCross InfectionMilk HumanPseudomonas aeruginosabusiness.industryInfant NewbornGeneral Medicinebacterial infections and mycosesneonatal intensive care unitAnti-Bacterial AgentsSurvival RateImipenemBreast FeedingPseudomonas aeruginosabreast milkFemalebusinessmedicine.drugActa pharmacologica Sinica
researchProduct

Meningitis due to Pseudomonas stutzeri in a patient infected with human immunodeficiency virus.

1996

Microbiology (medical)AdultMalebiologyAIDS-Related Opportunistic Infectionsbusiness.industrybiology.organism_classificationmedicine.diseaseVirologyMicrobiologyPseudomonas stutzeriMeningitis BacterialInfectious DiseasesAcquired immunodeficiency syndrome (AIDS)ImmunopathologyPseudomonasPseudomonadalesMedicineHumansPseudomonas InfectionsViral diseasebusinessSidaMeningitisPseudomonadaceaeClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis

2021

Abstract We describe a challenging case of patient with metallo-beta-lactamase-producing Pseudomonas aeruginosa sternal osteomyelitis following aortic valve replacement with biological prosthesis. The strain exhibited a multidrug-resistance phenotype carrying the blaVIM-1 gene and belonged to the high-risk clone sequence type ST235. The patient was successfully treated with surgical debridement plus antibiotic therapy with ceftazidime/avibactam, aztreonam, and amikacin. Time-kill curves showed that this triple antibiotic combination at 1 × MIC was strongly synergic after 8 h, achieving 99.9% killing and maintaining this until 48 h.

Microbiology (medical)AvibactamDrug ResistanceCeftazidimeInfectious and parasitic diseasesRC109-216Aztreonammedicine.disease_causeST235CeftazidimeMicrobiologyCeftazidime–avibactamchemistry.chemical_compoundAztreonamAortic valve replacementDrug TherapyDrug Resistance Multiple BacterialmedicineHumansPseudomonas InfectionsPseudomonas aeruginosa; ST235; VIM-1; aztreonam; ceftazidime-avibactam; osteomyelitisAmikacinAgedPseudomonas aeruginosabusiness.industryceftazidime-avibactamOsteomyelitisBacterialOsteomyelitisGeneral MedicineCeftazidime/avibactammedicine.diseaseAnti-Bacterial AgentsDrug CombinationsInfectious DiseaseschemistryDebridementAmikacinPseudomonas aeruginosaCombinationVIM-1Drug Therapy CombinationFemalebusinessAzabicyclo CompoundsMultiplemedicine.drug
researchProduct

In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneum…

2008

In this study, we compared the efficacy of ceftazidime (CAZ) intermittent versus continuous infusion with or without tobramycin (TOB) for the treatment of pneumonia caused by Pseudomonas aeruginosa in rabbits. Treatments were humanised and mimicked intermittent CAZ (iCAZ) (2g three times daily), continuous CAZ (cCAZ) (4g once daily (qd)) and TOB (10mg/kg qd). Minimum inhibitory concentrations (MICs) were 1mg/L and 4mg/L for TOB and CAZ, respectively. Bacterial efficacy in lungs was as follows: control, 9+/-0.6 colony-forming units (CFU)/g; TOB monotherapy, 8+/-0.5CFU/g; iCAZ monotherapy, 7.8+/-1.4CFU/g; cCAZ monotherapy, 8+/-0.4CFU/g (P = 0.005); and iCAZ+TOB, 8+/-0.5CFU/g; cCAZ+TOB, 7.2+/-…

Microbiology (medical)Malemedicine.drug_classAntibioticsColony Count MicrobialCeftazidimeMicrobial Sensitivity TestsCeftazidimeMicrobiologyPseudomonas infectionmedicineTobramycinPneumonia BacterialAnimalsHumansPharmacology (medical)Pseudomonas InfectionsInfusions IntravenousLungAntibacterial agentProtein synthesis inhibitorbusiness.industryAminoglycosideGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesPharmacodynamicsTobramycinDrug Therapy CombinationRabbitsbusinessSpleenmedicine.drugInternational journal of antimicrobial agents
researchProduct

Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa.

2011

The aims of this study were to ascertain the presence and spread of class 1 integrons amongst environmental and clinical isolates of Pseudomonas aeruginosa and to characterise their variable regions. A total of 76 isolates (56 clinical and 20 environmental) were studied. The presence of plasmids was explored, and polymerase chain reaction (PCR) was used for integron detection. All amplicons were sequenced. PCR detected class 1 integrons in 26 of the 56 clinical isolates; environmental isolates were integron-free. No plasmids were found, thus all the integrons found are possibly on the chromosome. Most isolates presented one amplicon, except PA110514 and PA116136, which showed two PCR produc…

Microbiology (medical)Transposable elementDNA BacterialMicrobial Sensitivity TestsBiologymedicine.disease_causeIntegronPolymerase Chain Reactionlaw.inventionMicrobiologyIntegronsPlasmidAntibiotic resistancelawDrug Resistance Multiple BacterialmedicineHumansPharmacology (medical)Pseudomonas InfectionsPolymerase chain reactionGeneticsPseudomonas aeruginosaGeneral Medicinebiochemical phenomena metabolism and nutritionAmpliconAnti-Bacterial AgentsBacterial Typing TechniquesInfectious DiseasesFomitesHorizontal gene transferPseudomonas aeruginosabiology.proteinbacteriaWater MicrobiologyPlasmidsInternational journal of antimicrobial agents
researchProduct